Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Myelin mapping in the central nervous system of living mice using contrast-enhanced magnetization transfer MRI.

Watanabe T, Frahm J, Michaelis T.

Neuroimage. 2012 Nov 1;63(2):812-7. doi: 10.1016/j.neuroimage.2012.06.073. Epub 2012 Jul 14.

PMID:
22796983
[PubMed - indexed for MEDLINE]
2.

Myelin mapping in the living mouse brain using manganese-enhanced magnetization transfer MRI.

Watanabe T, Frahm J, Michaelis T.

Neuroimage. 2010 Jan 15;49(2):1200-4. doi: 10.1016/j.neuroimage.2009.09.050. Epub 2009 Sep 28.

PMID:
19796698
[PubMed - indexed for MEDLINE]
3.

Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.

Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.

Acta Radiol. 2010 Feb;51(1):78-84. doi: 10.3109/02841850903350178.

PMID:
19912078
[PubMed - indexed for MEDLINE]
4.

Improvement of brain lesion detection at 0.1 T by simultaneous use of Gd-DTPA and magnetization transfer imaging.

Ramadan UA, Aronen HJ, Tanttu JI, Karjalainen PT, Kairemo KJ, Jääskeläinen J, Sipilä L, Häkkinen AM.

Magn Reson Med. 1997 Feb;37(2):268-74.

PMID:
9001152
[PubMed - indexed for MEDLINE]
5.

Application of magnetization transfer imaging for intracranial lesions of tuberous sclerosis.

Jeong MG, Chung TS, Coe CJ, Jeon TJ, Kim DI, Joo AY.

J Comput Assist Tomogr. 1997 Jan-Feb;21(1):8-14.

PMID:
9022761
[PubMed - indexed for MEDLINE]
6.

Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.

Korkusuz H, Knau LL, Kromen W, Bihrer V, Keese D, Piiper A, Vogl TJ.

J Magn Reson Imaging. 2012 Jun;35(6):1397-402. doi: 10.1002/jmri.23584. Epub 2012 Jan 20.

PMID:
22267126
[PubMed - indexed for MEDLINE]
7.

Delayed gadolinium-enhanced magnetic resonance imaging (dGEMRIC) of hip joint cartilage: better cartilage delineation after intra-articular than intravenous gadolinium injection.

Boesen M, Jensen KE, Qvistgaard E, Danneskiold-Samsøe B, Thomsen C, Ostergaard M, Bliddal H.

Acta Radiol. 2006 May;47(4):391-6.

PMID:
16739699
[PubMed - indexed for MEDLINE]
8.

Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.

Silver NC, Good CD, Barker GJ, MacManus DG, Thompson AJ, Moseley IF, McDonald WI, Miller DH.

Brain. 1997 Jul;120 ( Pt 7):1149-61.

PMID:
9236628
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.

Colosimo C, Demaerel P, Tortori-Donati P, Christophe C, Van Buchem M, Högström B, Pirovano G, Shen N, Kirchin MA, Spinazzi A.

Pediatr Radiol. 2005 May;35(5):501-10. Epub 2005 Jan 28.

PMID:
15678342
[PubMed - indexed for MEDLINE]
10.

Synergistic enhancement of MRI with Gd-DTPA and magnetization transfer.

Tanttu JI, Sepponen RE, Lipton MJ, Kuusela T.

J Comput Assist Tomogr. 1992 Jan-Feb;16(1):19-24.

PMID:
1729300
[PubMed - indexed for MEDLINE]
11.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
[PubMed - indexed for MEDLINE]
12.

Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.

Bangard C, Stippel DL, Berg F, Kasper HU, Hellmich M, Fischer JH, Hölscher A, Lackner K, Gossmann A.

J Magn Reson Imaging. 2008 Jul;28(1):263-70. doi: 10.1002/jmri.21423.

PMID:
18581392
[PubMed - indexed for MEDLINE]
13.

Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.

Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.

Eur J Radiol. 2012 Oct;81(10):2457-62. doi: 10.1016/j.ejrad.2011.10.014. Epub 2011 Dec 3.

PMID:
22138122
[PubMed - indexed for MEDLINE]
14.

Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.

Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.

Acad Radiol. 2006 Jun;13(6):744-51.

PMID:
16679277
[PubMed - indexed for MEDLINE]
15.

Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.

Feng Y, Jeong EK, Mohs AM, Emerson L, Lu ZR.

Magn Reson Med. 2008 Dec;60(6):1347-52. doi: 10.1002/mrm.21791.

PMID:
19025902
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.

Han D, Chang KH, Han MH, Cho JY, Han SW, Kim HD, Seong SO.

AJR Am J Roentgenol. 1998 Jan;170(1):189-93.

PMID:
9423630
[PubMed - indexed for MEDLINE]
17.

Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.

Haar PJ, Broaddus WC, Chen ZJ, Fatouros PP, Gillies GT, Corwin FD.

Phys Med Biol. 2010 Jun 21;55(12):3451-65. doi: 10.1088/0031-9155/55/12/012. Epub 2010 May 28.

PMID:
20508321
[PubMed - indexed for MEDLINE]
18.

MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA.

Simon GH, von Vopelius-Feldt J, Wendland MF, Fu Y, Piontek G, Schlegel J, Chen MH, Daldrup-Link HE.

J Magn Reson Imaging. 2006 May;23(5):720-7.

PMID:
16557494
[PubMed - indexed for MEDLINE]
19.

Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.

Fujinaga Y, Ohya A, Matsushita T, Kurozumi M, Ueda K, Kitou Y, Ueda H, Kadoya M.

Jpn J Radiol. 2011 Dec;29(10):695-700. doi: 10.1007/s11604-011-0615-5. Epub 2011 Oct 19.

PMID:
22009420
[PubMed - indexed for MEDLINE]
20.

Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.

Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM.

Acad Radiol. 2011 Dec;18(12):1549-54. doi: 10.1016/j.acra.2011.08.007. Epub 2011 Sep 29.

PMID:
21958599
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk